Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 30 July 2009, Vol. 114, No. 5, pp. 932-933.

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Kahr, W. H. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kahr, W. H. A.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

InsideBlood

PLATELETS & THROMBOPOIESIS

Comment on Graham et al, page 1083

Granules and thrombus formation

Walter H. A. Kahr

UNIVERSITY OF TORONTO

Abstract

In this issue of Blood, Graham and colleagues demonstrate the importance of platelet dense granule secretion for in vivo platelet accumulation following laser injury, which is mediated by the SNARE protein Endobrevin/VAMP-8.

Each human platelet contains 50 to 80 {alpha}-granules, 3 to 8 dense ({delta}-) granules, and a few lysosomes. {alpha}-granules carry more than 300 releasable proteins, including adhesion molecules, chemokines, cytokines, fibrinolytic regulators, immunologic modulators, and an assortment of coagulation, complement, growth, and proangiogenic and antiangiogenic factors. Dense granules contain mostly small molecules, including calcium, magnesium, polyphosphate, ATP, ADP, GTP, GDP, and serotonin. Platelet granule release is important for hemostasis, because patients with inherited granule defects have bleeding problems. {alpha}-granules are absent in the gray platelet and ARC1 syndromes, while deficient {delta}-granules are observed in isolation, in combination with {alpha}-granule deficiency, or as part of a syndrome in the Hermansky-Pudlak, Chediak-Higashi, and Griscelli syndromes.2


Figure 1
View larger version (57K):
[in this window]
[in a new window]

 
Platelet granule secretion requires SNARE proteins. Platelets contain {alpha}-granules, dense ({delta}-) granules, and a few lysosomes. Platelet activation results in cytoskeletal rearrangements, centralization of granules, and fusion of granules with the target membrane (plasma membrane or the open canalicular system). Secretion involves the assembly of granule v-SNAREs (eg, VAMP-8) and target membrane t-SNAREs (eg, syntaxin 2, SNAP-23) into a complex allowing membrane fusion and exocytosis.

 
The molecular mechanisms involved in platelet granule secretion are complex and incompletely understood.35 Platelet activation involves several rapid events, including shape change, aggregation, and granule secretion, and it is difficult to discern the cellular mechanisms involved. Electron microscopy studies have revealed that platelet shape changes are accompanied by cytoskeletal rearrangements and centralization of granules. Platelet exocytosis involves fusion of granules with the plasma membrane or the open canalicular system (extensive channels of internal membranes that communicate with the outer surface) to release their contents into the extracellular space (see figure). Fusion of granule vesicles requires soluble N-ethylmaleimide–sensitive attachment protein receptors (SNAREs), lipid components, and SNARE regulatory proteins (eg, NSF, Sec1/Munc18 proteins).6 SNAREs from opposing membranes assemble into a complex consisting of parallel 4-helix bundles, which catalyzes the apposition and fusion of the vesicle with the target membrane. Platelets contain vesicle-membrane SNAREs (v-SNAREs), including VAMP-2, -3, -7, and -8, and target-membrane SNAREs (t-SNAREs), including syntaxin 2, 4, 7, and 11, and SNAP-23, -25 and -29.4 Studies have shown that syntaxin 2 and SNAP-23 are involved in all 3 platelet granule secretion events, whereas syntaxin 4 mediates {alpha}-granule and lysosome release. VAMP-8 is the primary v-SNARE required for secretion of all platelet granules.7

The studies by Graham et al in this issue of Blood reveal the importance of dense granule secretion for in vivo platelet accumulation following laser injury of cremaster arterioles.8 The most striking observation is that dense granule deficient mice (ruby-eye mice) show almost no platelet accumulation at injury sites, indicating that molecules released by dense granules are necessary for efficient thrombus formation. In VAMP-8–/– mice, thrombus formation is delayed and decreased (but not absent) following laser injury, suggesting that the v-SNARE Endobrevin/VAMP-8 is an important component of in vivo platelet granule secretion. The incomplete inhibition of platelet accumulation at sites of injury in VAMP-8–/– mice was somewhat surprising because VAMP-8 mediates the release of all platelet granules, hence an additive effect might have been expected. The results can be explained by functional redundancy of SNAREs, whereby VAMP-2 or -3 can mediate granule release in the absence of VAMP-8.7 The authors observe that VAMP-2 and VAMP-8 levels are comparable in mouse platelets, whereas VAMP-3 and VAMP-8 levels are comparable in human platelets. As VAMP-2 levels are greatly diminished in human platelets, this suggests that the major alternative granule v-SNARE in humans is VAMP-3.

The dense granule constituents responsible for mediating platelet accumulation in vivo were examined in vitro via aggregation studies of plasma-free washed platelets. Compared with wild-type, platelets from VAMP-8–/– and ruby-eye mice required 1.5- to 10-fold higher concentrations of thrombin for complete aggregation, while addition of exogenous ADP produced normal aggregation responses at low thrombin concentrations. The function of PKC{alpha}–/– mouse platelets (which have impaired dense granule biogenesis and defective secretion of both dense and {alpha}-granules) can also be restored by ADP in vitro.9 Thus, ADP is a key dense granule component, and its release during activation is likely required for efficient platelet accumulation at vascular injury sites. The thrombus formation defects observed in ruby-eye mice indicate that in vivo thrombin generation following laser injury cannot compensate for the absence of dense granule secretion.

Although these studies provide important new insights into the role of platelet granule secretion in vivo, some questions do remain. For example, which SNAREs and regulatory proteins control selective secretion from granules, including the recently discovered distinct populations of {alpha}-granules?10 What contribution does {alpha}-granule secretion make to thrombus formation in vivo? The availability of megakaryocyte-restricted gene knockout mice will undoubtedly shed light on some of these questions. Importantly, the current studies suggest that antiplatelet therapies targeting granule secretion could attenuate acute thrombus formation and also reduce the development of chronic atherosclerotic lesions by inhibiting the release of inflammatory and immune-modulating factors from platelets.

Footnotes

Conflict-of-interest disclosure: The author declares no competing financial interests. {blacksquare}

REFERENCES

  1. Lo B, Li L, Gissen P, et al. Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet {alpha}-granule biogenesis. Blood. 2005;106:4159–4166.[Abstract/Free Full Text]

  2. Nurden P, Nurden AT. Congenital disorders associated with platelet dysfunctions. Thromb Haemost. 2008;99:253–263.[Medline] [Order article via Infotrieve]

  3. Flaumenhaft R. Molecular basis of platelet granule secretion. Arterioscler Thromb Vasc Biol. 2003;23:1152–1160.[Abstract/Free Full Text]

  4. Ren Q, Ye S, Whiteheart SW. The platelet release reaction: just when you thought platelet secretion was simple. Curr Opin Hematol. 2008;15:537–541.[CrossRef][Medline] [Order article via Infotrieve]

  5. Reed GL. Platelet secretory mechanisms. Semin Thromb Hemost. 2004;30:441–450.[CrossRef][Medline] [Order article via Infotrieve]

  6. Südhof TC, Rothman JE. Membrane fusion: grappling with SNARE and SM proteins. Science. 2009;323:474–477.[Abstract/Free Full Text]

  7. Ren Q, Barber HK, Crawford GL, et al. Endobrevin/VAMP-8 is the primary v-SNARE for the platelet release reaction. Mol Biol Cell. 2007;18:24–33.[Abstract/Free Full Text]

  8. Graham GJ, Ren Q, Dilks JR, Blair P, Whiteheart SW, Flaumenhaft R. Endobrevin/VAMP-8–dependent dense granule release mediates thrombus formation in vivo. Blood. 2009;114:1083–1090.[Abstract/Free Full Text]

  9. Konopatskaya O, Gilio K, Harper MT, et al. PKC{alpha} regulates platelet granule secretion and thrombus formation in mice. J Clin Invest. 2009;119:399–407.[Medline] [Order article via Infotrieve]

  10. Italiano JE Jr, Richardson JL, Patel-Hett S, et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood. 2008;111:1227–1233.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Endobrevin/VAMP-8–dependent dense granule release mediates thrombus formation in vivo
Gwenda J. Graham, Qiansheng Ren, James R. Dilks, Price Blair, Sidney W. Whiteheart, and Robert Flaumenhaft
Blood 2009 114: 1083-1090. [Abstract] [Full Text] [PDF]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Kahr, W. H. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kahr, W. H. A.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020